IT1232827B - BIOLOGICALLY ACTIVE PROTEINS, FORMULATIONS CONTAINING THEM AND METHOD TO PREPARE AND APPLY THEM - Google Patents

BIOLOGICALLY ACTIVE PROTEINS, FORMULATIONS CONTAINING THEM AND METHOD TO PREPARE AND APPLY THEM

Info

Publication number
IT1232827B
IT1232827B IT8947794A IT4779489A IT1232827B IT 1232827 B IT1232827 B IT 1232827B IT 8947794 A IT8947794 A IT 8947794A IT 4779489 A IT4779489 A IT 4779489A IT 1232827 B IT1232827 B IT 1232827B
Authority
IT
Italy
Prior art keywords
prepare
apply
biologically active
formulations containing
active proteins
Prior art date
Application number
IT8947794A
Other languages
Italian (it)
Other versions
IT8947794A0 (en
Inventor
Jean-Michel Dayer
Philippe Lucien Seckinger
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8947794A0 publication Critical patent/IT8947794A0/en
Application granted granted Critical
Publication of IT1232827B publication Critical patent/IT1232827B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IT8947794A 1988-03-31 1989-03-30 BIOLOGICALLY ACTIVE PROTEINS, FORMULATIONS CONTAINING THEM AND METHOD TO PREPARE AND APPLY THEM IT1232827B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807803A GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product

Publications (2)

Publication Number Publication Date
IT8947794A0 IT8947794A0 (en) 1989-03-30
IT1232827B true IT1232827B (en) 1992-03-05

Family

ID=10634493

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8947794A IT1232827B (en) 1988-03-31 1989-03-30 BIOLOGICALLY ACTIVE PROTEINS, FORMULATIONS CONTAINING THEM AND METHOD TO PREPARE AND APPLY THEM

Country Status (12)

Country Link
JP (1) JPH02117700A (en)
KR (1) KR890014125A (en)
AU (1) AU3228789A (en)
BE (1) BE1001845A4 (en)
DE (1) DE3910323A1 (en)
DK (1) DK156589A (en)
FR (1) FR2629345A1 (en)
GB (2) GB8807803D0 (en)
IL (1) IL89804A0 (en)
IT (1) IT1232827B (en)
NL (1) NL8900779A (en)
SE (1) SE8901115L (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5811261A (en) * 1988-09-12 1998-09-22 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
ES2238070T3 (en) * 1989-04-21 2005-08-16 Amgen Inc. TNF RECEPTOR, TNF BINDING PROTEIN AND CODANT DNA FOR THESE.
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
AU630497B2 (en) * 1989-09-05 1992-10-29 Immunex Corporation Tumor necrosis factor-alpha and -beta receptors
US5945397A (en) * 1989-09-05 1999-08-31 Immunex Corporation Purified p75 (type II) tumor necrosis factor receptor polypeptides
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
DE10399023I2 (en) * 1989-09-12 2006-11-23 Ahp Mfg B V TFN-binding proteins
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1992001002A1 (en) * 1990-07-11 1992-01-23 Teijin Limited Tumor necrosis factor activity inhibitor and production thereof
US5304634A (en) * 1990-10-12 1994-04-19 Hoechst Aktiengesellschaft Inhibitors for the formation of tumor necrosis factor
KR100234520B1 (en) * 1991-01-18 1999-12-15 그레고리 아보트 Pharmaceutical composition for treating tumor necrosis factor mediated diseases
JPH06510122A (en) * 1991-08-23 1994-11-10 エヌチップ　インコーポレイテッド Burn-in techniques for unpackaged integrated circuits
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
DE69724451T2 (en) 1996-12-06 2004-03-18 Amgen Inc., Thousand Oaks COMBINATION THERAPY WITH A TNF-BINDING PROTEIN FOR TREATING DISEASES CAUSED BY TNF
CA2273852C (en) 1996-12-06 2009-09-29 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
ES2674888T3 (en) 2001-06-26 2018-07-04 Amgen Inc. OPGL antibodies
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
JP2006517191A (en) 2002-12-30 2006-07-20 アムジエン・インコーポレーテツド Combination therapy using costimulatory factors
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
LT2523688T (en) 2010-01-15 2018-03-12 Kirin-Amgen, Inc. Antibody formulation and therapeutic regimens
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
KR102530900B1 (en) 2014-03-31 2023-05-12 암젠 케이-에이, 인크. Methods of treating nail and scalp psoriasis

Also Published As

Publication number Publication date
IL89804A0 (en) 1989-09-28
BE1001845A4 (en) 1990-03-20
JPH02117700A (en) 1990-05-02
KR890014125A (en) 1989-10-21
IT8947794A0 (en) 1989-03-30
DK156589D0 (en) 1989-03-30
DE3910323A1 (en) 1989-10-19
GB8907148D0 (en) 1989-05-10
FR2629345A1 (en) 1989-10-06
GB2218101A (en) 1989-11-08
SE8901115D0 (en) 1989-03-30
NL8900779A (en) 1989-10-16
AU3228789A (en) 1989-10-05
DK156589A (en) 1989-10-01
GB8807803D0 (en) 1988-05-05
SE8901115L (en) 1989-10-01

Similar Documents

Publication Publication Date Title
IT1232827B (en) BIOLOGICALLY ACTIVE PROTEINS, FORMULATIONS CONTAINING THEM AND METHOD TO PREPARE AND APPLY THEM
FR2630546B1 (en) ENZYMATIC ELECTRODE AND ITS PREPARATION METHOD
NO865076L (en) MORE TIMES DIVIDED TRANSDERMAL AND DERMAL PLASTERS.
IT8520242A0 (en) PHYSIOLOGICALLY ACTIVE HUMAN POLYPEPTIDE.
IT1208521B (en) ELECTRODE, APPARATUS AND DEFIBRILLATION FOR IMPLANTATION IN HUMAN OR ANIMAL BODIES.
JPS539762A (en) Hydoxyysuccinimideeester derivative* its preparation and method of bonding biologically active proteins
DK273689A (en) 4-AMINO-3-CARBOXYQUINOLINES AND -NAPHTHYRIDINES, PROCEDURES FOR THEIR PREPARATION AND USE OF THEM IN PHARMACEUTICALS
IT1196484B (en) YEAST EXPRESSION AND SECRETION VECTOR, USEFUL FOR THE PREPARATION OF HETEROLOGICAL PROTEINS
EP0325404A3 (en) Method of immobilizing physiologically active substances
HUT44251A (en) Insecticidal and nematocidal preparations comprising 5-azolyl-1-aryl-pyrazoles as active substance and process for preparing the active substances
DK291886D0 (en) 1,8-BROWN-CONNECTED 4-QUINOLON-3-CARBOXYLIC ACIDS, THEIR PREPARATION AND USE IN PHARMACEUTICALS AND ANIMAL FEEDS
DK109590A (en) BIOLOGICAL ACTIVE PROTEIN
IS3514A7 (en) Method for working biologically active substances
DK586586A (en) BIOLOGICALLY ACTIVE AMID DERIVATIVES
DK183585D0 (en) IMINOTHIAZOLIDE INGREDIENTS, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS THEREOF
FR2627778B1 (en) STRUCTURAL GENE, CORRESPONDING ENDOTOXIN PROTEIN, AND INSECTICIDE APPLICATION
FR2597091B1 (en) BIOLOGICALLY ACTIVE PERMANENT IMPLANTS
FR2579599B1 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCE TPI AND PREPARATION METHOD
FR2584401B1 (en) NOVEL BENZAMIDE, METHOD FOR PREPARING THE SAME, AND APPLICATION THEREOF IN THE THERAPEUTIC FIELD
FR2540107B1 (en) NOVEL HALOGENOBENZOPHENONE-OXIME DERIVATIVES, THERAPEUTIC USE AND PREPARATION METHOD
DK146686D0 (en) NITROMETHYLENE-TETRAHYDROPYRIMIDINES, THEIR PREPARATION AND APPLICATION AS INSECTICIDES
DE3787371T2 (en) BIOLOGICALLY ACTIVE AGENT.
FR2626880B1 (en) N-SUBSTITUTED DERIVATIVES OF 2-AMINO-1-PHENYLPROPANONE, METHOD OF PREPARATION AND THERAPEUTIC USE
DE3782199T2 (en) BIOLOGICALLY ACTIVE PEPTIDE TAN-866.
PH22500A (en) Biologically active copolymers, preparation and method of use thereof